Diabetic Mastopathy Diagnosis

NewsGuard 100/100 Score

Diabetic mastopathy (DMP) is usually discovered by the patients themselves and they describe it as an irregular and painless lump. After informing their family physician, screening procedures for breast cancer will begin, which includes mammograms and breast ultrasound studies.

mammogramImage Credit: Chompoo Suriyo / Shutterstock.com

Once imaging studies are over and if the findings are inconclusive, a biopsy is performed to confirm the findings and rule out breast cancer. Histological analysis is an important method that helps differentiate DMP from breast carcinoma.

DMP lesions are of various sizes and can be present in any of the quadrants of the breast, though it is more common for them to appear in the subareolar region. Specific features of DMP are generally not clear from imaging studies, though a discrete mass with pronounced acoustic shadowing is evident in ultrasonograms. Also, mammograms can reveal homogenous and dense glandular tissue with no signs of microcalcification or architectural distortion. Unfortunately, radiologic and clinical studies do not help much in differentiating DMP from breast cancer.

The radiographic features of DMP that may be used in the diagnosis of diabetic mastopathy are outlined below.

Mammography in diabetic mastopathy

Mammographic findings of breast masses usually show poorly defined lesions often surrounded by glandular tissue. This makes mammographic studies more difficult in the case of DMP.

Breast ultrasound in diabetic mastopathy

An ultrasound of the breast often reveals shapeless masses that are hypoechoic with clear posterior acoustic shadowing. Sonographic features often mimic features of more severe cases such as breast carcinoma.

Breast MRI in diabetic mastopathy

MRI of the breast leads to a range of findings from less diffuse contrast material enhancement to rapid, intense enhancement that is indistinguishable from breast carcinoma.

Clinical findings are mostly inconclusive after imaging and these masses are more often misdiagnosed by physicians as breast carcinoma. Identifying this condition precisely and differentiating it from carcinoma is critical in avoiding unnecessary surgical procedures.

DIABETIC MASTOPATHY BY DR WAFAEY BADAWY

Histological examination in diabetic mastopathy

Histological study is the only way to confirm the diagnosis of DMP. Histological examination of DMP masses shows firm, white, homogenous lesions that are separated to an extent from the surrounding breast tissue. There is clear fibrosis and the presence of lymphocytes around the ducts and lobules. Very little to no adipose tissue or cellular materials are seen during histological analysis. Cytological images in the case of DMP show extensive infiltration of the ducts, vessels, and lobes by mature lymphocytes. General pathognomonic findings specific to DMP include epithelioid fibroblasts, keloidal fibrosis, and lymphocytic ductitis or lobulitis.

Sampling using fine needle aspiration is difficult because DMP masses are usually resistant to needle passes. Also, the cellular yield is usually insufficient for diagnostic needs in up to 70% of patients with DMP. Hence, core biopsy is a better approach in terms of diagnostic yield.

Differential diagnosis in diabetic mastopathy

Pathologists need to be very careful during the diagnosis of DMP as it is easy to misdiagnose and it can recur after some time. As DMP masses look similar to those in breast carcinoma, pathologists and radiologists should be able to differentiate between the two. A correct diagnosis can save patients from unwanted surgical biopsies. No evidence exists to suggest that DMP leads to breast cancer or stromal neoplastic diseases.

Careful correlation of the medical history of the patient with the radiological, physical, and pathological investigations is very important for the diagnosis of DMP. Post confirmation of diagnosis, the patients can be monitored by fine-needle aspiration cytology (FNAC), which is a diagnostic method for investigating masses or lumps.

References

Further Reading

Last Updated: Jan 28, 2021

Susha Cheriyedath

Written by

Susha Cheriyedath

Susha is a scientific communication professional holding a Master's degree in Biochemistry, with expertise in Microbiology, Physiology, Biotechnology, and Nutrition. After a two-year tenure as a lecturer from 2000 to 2002, where she mentored undergraduates studying Biochemistry, she transitioned into editorial roles within scientific publishing. She has accumulated nearly two decades of experience in medical communication, assuming diverse roles in research, writing, editing, and editorial management.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Cheriyedath, Susha. (2021, January 28). Diabetic Mastopathy Diagnosis. News-Medical. Retrieved on April 18, 2024 from https://www.news-medical.net/health/Diabetic-Mastopathy-Diagnosis.aspx.

  • MLA

    Cheriyedath, Susha. "Diabetic Mastopathy Diagnosis". News-Medical. 18 April 2024. <https://www.news-medical.net/health/Diabetic-Mastopathy-Diagnosis.aspx>.

  • Chicago

    Cheriyedath, Susha. "Diabetic Mastopathy Diagnosis". News-Medical. https://www.news-medical.net/health/Diabetic-Mastopathy-Diagnosis.aspx. (accessed April 18, 2024).

  • Harvard

    Cheriyedath, Susha. 2021. Diabetic Mastopathy Diagnosis. News-Medical, viewed 18 April 2024, https://www.news-medical.net/health/Diabetic-Mastopathy-Diagnosis.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Maternal diabetes linked to a slight increase in ADHD risk in children